This HND piece examines some exciting developments in the often-touted, but only recently successful field of gene therapy. Ever since the discovery of DNA's double helical structure, people were talking about the possibilities, and now we have some real clinical trials that appear quite promising.
Our guide to the world of gene therapy is Jeff Galvin of American Gene Technologies International Inc., one of the companies that is close to some significant breakthroughs, including treatments for liver and prostate cancer. Other disease specific treatments are described, as well.
Read the complete article.